All systems operational
Q3 2025

Selective Immunoglobulin A Deficiency Among Omani Patients Screened for Celiac Disease: A Cross-sectional Study

Iman Nasr · Manal Al Kindi · Salma Al Abri · Mahmood Al Kindi · Zainab Ansari · Bushra Al Hinai · Ozay Mohamed · Salah Al Awaidy
10.5001/omj.2025.60 387 Views 0 Citations
0
Citations
387
Views
Abstract

Objectives: Selective immunoglobulin A deficiency (SIgAD) is characterized by an isolated deficiency of serum IgA while immunoglobulin G (IgG) and immunoglobulin M (IgM) levels remain normal. Symptoms range from asymptomatic to recurrent infections. We aimed to determine the prevalence of IgAD and SIgAD among Omani patients undergoing screening for celiac disease. Methods: This cross-sectional study included Omani nationals aged above one year, who were screened for celiac disease with anti-tissue transglutaminase (anti-tTG) IgA at Royal Hospital, Muscat, from January 2005 to December 2023. IgAD was defined as a total serum IgA level below the age-dependent reference range. SIgAD was diagnosed when both IgG and IgM values were within their respective reference limits. The prevalence of IgAD and SIgAD was statistically reviewed. Results: Of the 9615 individuals who underwent screening for celiac disease, 114 had low IgA levels. The prevalence of IgAD was 1.2%, and among these, 0.4% were confirmed to have SIgAD. The majority were > 14 years. Patients aged 6–14 years and > 14 years were more likely to have IgAD compared to 1–2 years old. Only 39 (34.2%) patients underwent further testing to confirm SIgAD, while the remaining 75 (65.8%) did not undergo follow-up IgG and IgM testing. Among the patients with confirmed SIgAD, 11 (28.2%) underwent further testing with anti-tTG IgG antibody, with only one (9.1%) testing positive for celiac disease as confirmed by esophagogastroduodenoscopy (EGD) and histopathology. Patients with anti-tTG IgG and EGD exhibited a significantly increased risk of low IgA levels. The remaining 28 (71.8%) patients did not undergo further celiac disease workup (anti-tTG IgG antibody, EGD, or genetic testing). Conclusions: IgAD was present in 1.2% of Omani patients evaluated for celiac disease, and 0.4% had confirmed SIgAD. Referral to an immunologist is recommended when IgG/IgM levels are low or infections are recurrent.

Cite this Article (APA)
Iman, N., Manal, A. K., Salma, A. A., Mahmood, A. K., Zainab, A., Bushra, A. H., Ozay, M., Salah, A. A. (2025). Selective Immunoglobulin A Deficiency Among Omani Patients Screened for Celiac Disease: A Cross-sectional Study. Oman Medical Journal. https://doi.org/10.5001/omj.2025.60
Related Papers
Epidemiology of Pediatric Trauma and its Outcome Presenting to an Emergency Department in a Tertiary…
Niranjan Lal Jeswani; Sumaira Iram; Firas Mohammed Shalash; Rabiya Faraz; Huyam · 2025
6
cites
399
Osteoarthritis Flare-up Secondary to Zoledronic Acid Infusion: A Case Report
Maisa H. Al Kiyumi; Maryam Al Kiyumi; Amira Al Harrasi; Yaqoub Al Saidi; Hana Al · 2025
3
cites
397
Depressive Symptoms Among Students of Sultan Qaboos University, Oman: A Cross-sectional Study
Asma Ali Al Salmani; Rahma Al Kindi; Nouf Al Alawi; Buthaina Al Maskari; Roaa Th · 2025
3
cites
392
A Genetic Clue to T2DM in Bangladesh: The TCF7L2 rs12255372 (G/T) Variant
Syed Azmal Mahmood; Md Fariduddin; Laila Anjuman Banu; Shoaib Hossain; Md Mohiud · 2025
3
cites
392
3
cites
392
Access
View Full Text via DOI
Published in
ISSN 1999-768X
Quartile Q3
AMS Score 79
Field Medicine & Health Sciences
Publisher Oman Medical Specialty Board
Country 🇴🇲 Oman
View Journal Profile →
Authors
Publication Details
Year 2025
Language English
Added 23 Jul 2026